Literature DB >> 6798590

Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats.

K Ohuchi, Y Kamada, L Levine, S Tsurufuji.   

Abstract

Glycyrrhizin was found to inhibit prostaglandin E2 production by activated rat peritoneal macrophages. Preincubation of the cells with glycyrrhizin increases its inhibitory effectiveness. Glycyrrhetinic acid, the aglycone of glycyrrhizin, at a dose of 100 microgram per ml also inhibited prostaglandin E2 production, but the inhibition was considered to be attributable to a toxic effect on the cells since more than 30% of the cells were detached from the dish during the 8 hr incubation period. In contrast, glycyrrhizin did not detach the cells from the dish at doses up to 3 mg per ml. Release of [3H]arachidonic acid from prelabeled cells was also inhibited by glycyrrhizin. It is likely that anti-inflammatory activity of glycyrrhizin depends at least in part on its inhibitory effect of the production of prostaglandin E2.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6798590     DOI: 10.1016/0161-4630(81)90033-1

Source DB:  PubMed          Journal:  Prostaglandins Med        ISSN: 0161-4630


  26 in total

1.  Safety implications regarding use of phytomedicines.

Authors:  Laura Cuzzolin; Silvana Zaffani; Giuseppina Benoni
Journal:  Eur J Clin Pharmacol       Date:  2005-12-03       Impact factor: 2.953

2.  Observing Anti-inflammatory and Anti-nociceptive Activities of Glycyrrhizin Through Regulating COX-2 and Pro-inflammatory Cytokines Expressions in Mice.

Authors:  Hong-Ling Wang; Yu-Xiang Li; Ya-Ting Niu; Jie Zheng; Jing Wu; Guang-Jiang Shi; Lin Ma; Yang Niu; Tao Sun; Jian-Qiang Yu
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

3.  Inhibition of human complement by beta-glycyrrhetinic acid.

Authors:  B H Kroes; C J Beukelman; A J van den Berg; G J Wolbink; H van Dijk; R P Labadie
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

4.  Medicinal plants in therapy.

Authors:  N R Farnsworth; O Akerele; A S Bingel; D D Soejarto; Z Guo
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

5.  Stimulation of arachidonic acid metabolism in rat peritoneal macrophages by thapsigargin, a non-(12-O-tetradecanoylphorbol-13-acetate) (TPA)-type tumor promoter.

Authors:  K Ohuchi; T Sugawara; M Watanabe; N Hirasawa; S Tsurufuji; H Fujiki; T Sugimura; S B Christensen
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

6.  Modulation of lipopolysaccharide-induced pro-inflammatory mediators by an extract of Glycyrrhiza glabra and its phytoconstituents.

Authors:  P Thiyagarajan; C V Chandrasekaran; H B Deepak; Amit Agarwal
Journal:  Inflammopharmacology       Date:  2011-02-17       Impact factor: 4.473

7.  Lectins modulate prostaglandin E2 production by rat peritoneal macrophages.

Authors:  K Ohuchi; M Watanabe; E Takahashi; S Tsurufuji; K Imanishi; I Suzuki; L Levine
Journal:  Agents Actions       Date:  1984-10

8.  Analysis of the stimulative effect of thapsigargin, a non-TPA-type tumour promoter, on arachidonic acid metabolism in rat peritoneal macrophages.

Authors:  K Ohuchi; T Sugawara; M Watanabe; N Hirasawa; S Tsurufuji; H Fujiki; S B Christensen; T Sugimura
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

9.  Pharmacological analysis of neutrophil chemotactic factor production by leucocytes and roles of PAF in allergic inflammation in rats.

Authors:  M Watanabe; Y Arakida; J Tanabe; A Sugidachi; N Hirasawa; S Mue; K Ohuchi
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

10.  The efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following carboplatin and paclitaxel combination chemotherapy for non-small cell lung cancer.

Authors:  Tsutomu Yoshida; Toshiyuki Sawa; Takashi Ishiguro; Akane Horiba; Shinya Minatoguchi; Hisayoshi Fujiwara
Journal:  Support Care Cancer       Date:  2008-10-07       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.